An article about our company appeared in Organization for Small & Medium Enterprises and Regional Innovation, JAPAN

NATiAS, a company that supports the creation of oligonucleotide therapeutics with its novel synthesis technology.

The Organization for Small & Medium Enterprises and Regional Innovation, Japan published an interview with our company in its BI Activity Report (FY2021), in which we talked about our motivation for starting a business and moving into MEDDEC, and our future business development.

Click here for the interview article (Japanese site).